FirsthandHealth
medRxiv PreprintsInternational15 November 2026

Perioperative Safety, Surgical Morbidity, and Survival Outcomes of Neoadjuvant Chemotherapy (NACT-IDS) versus Primary Debulking Surgery (PDS) in Elderly Patients with Advanced Epithelial Ovarian Cancer: A Systematic Review and Meta-Analysis

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

Abstract Background: Advanced epithelial ovarian cancer disproportionately affects older women. While primary debulking surgery (PDS) is the traditional gold standard, it carries substantial morbidity and mortality risks in frail, older patients. Neoadjuvant chemotherapy followed by interval debulking surgery (NACT-IDS) can downstage disease and mitigate these surgical risks, but high-level evidence syntheses specific to geriatric populations remain limited. Methods: This systematic review and meta-analysis adhered to PRISMA 2020 guidelines and was registered on PROSPERO (CRD420261461644). Fiv
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.